Collectively, these findings demonstrate that EWS/FLI1-driven tumors rely on CDK12-mediated DDR transcription, and that combined CDK12 and PARP inhibition represents a rational synthetic-lethal strategy in Ewing sarcoma [20]. The gene discussed is CDK12; the disease is Ewing sarcoma.